Cargando…
Medication-related osteonecrosis of the jaw: An update
Antiresorptive medications, such as bisphosphonates and denosumab, are an important class of medication used to treat a wide range of diseases from osteoporosis to multiple myeloma. Unfortunately, they are also associated with a rare but devastating side effect – medication-related osteonecrosis of...
Autor principal: | Bansal, Hitesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326203/ https://www.ncbi.nlm.nih.gov/pubmed/35911799 http://dx.doi.org/10.4103/njms.NJMS_236_20 |
Ejemplares similares
-
Update on Medication Related Osteonecrosis of the Jaws
por: Boyd, Barry C.
Publicado: (2023) -
Review and update on drugs related to the development of osteonecrosis of the jaw
por: Eguia, Asier, et al.
Publicado: (2020) -
Immune Dysfunction in Medication-Related Osteonecrosis of the Jaw
por: Roato, Ilaria, et al.
Publicado: (2023) -
Medication-related osteonecrosis of the jaw: Prosthodontic considerations
por: Ali, Islam E., et al.
Publicado: (2022) -
Role of Teriparatide in Medication-Related Osteonecrosis of the Jaws (MRONJ)
por: Kwon, Yong-Dae, et al.
Publicado: (2016)